Exploring beyond Common Cell Death Pathways in Oral Cancer: A Systematic Review
Biology,
Journal Year:
2024,
Volume and Issue:
13(2), P. 103 - 103
Published: Feb. 6, 2024
Oral
squamous
cell
carcinoma
(OSCC)
is
the
most
common
and
lethal
type
of
head
neck
cancer
in
world.
Variable
response
acquisition
resistance
to
traditional
therapies
show
that
it
essential
develop
novel
strategies
can
provide
better
outcomes
for
patient.
Understanding
cellular
molecular
mechanisms
death
control
has
increased
rapidly
recent
years.
Activation
pathways,
such
as
emerging
forms
non-apoptotic
programmed
death,
including
ferroptosis,
pyroptosis,
necroptosis,
NETosis,
parthanatos,
mitoptosis
paraptosis,
may
represent
clinically
relevant
therapeutic
opportunities.
This
systematic
review
summarizes
recently
described
OSCC,
highlighting
their
potential
informing
diagnosis,
prognosis
treatment.
Original
studies
explored
any
selected
deaths
OSCC
were
included.
Electronic
search,
study
selection,
data
collection
risk
bias
assessment
tools
realized.
The
literature
search
was
carried
out
four
databases,
extracted
from
79
articles
categorized
grouped
by
death.
Ferroptosis,
necroptosis
represented
main
studies,
with
links
immunity
inflammatory
responses,
progression
OSCC.
Harnessing
these
pathways
be
useful
patient-specific
individualized
therapy.
We
perspectives
on
how
different
types
integrated
decision
prognosis,
treatment
Language: Английский
From Genes to Metabolites: HSP90B1’s Role in Alzheimer’s Disease and Potential for Therapeutic Intervention
NeuroMolecular Medicine,
Journal Year:
2025,
Volume and Issue:
27(1)
Published: Jan. 6, 2025
Language: Английский
A bibliometric analysis of programmed cell death in oral cancer literature: research patterns and emerging trends (2000–2024)
Wenli Gu
No information about this author
Discover Oncology,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: April 22, 2025
Language: Английский
Exploring cell death pathways in oral cancer: mechanisms, therapeutic strategies, and future perspectives
Chenyi Zhao
No information about this author
Discover Oncology,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: March 26, 2025
Oral
squamous
cell
carcinoma
(OSCC)
represents
a
significant
global
health
challenge,
characterized
by
aggressive
progression
and
poor
therapeutic
response
despite
advances
in
treatment
modalities.
This
review
provides
comprehensive
analysis
of
diverse
death
mechanisms
OSCC,
encompassing
traditional
pathways
(apoptosis,
autophagy,
necrosis),
newly
(ferroptosis,
pyroptosis,
necroptosis),
emerging
(cuproptosis,
anoikis,
parthanatos,
entosis).
By
examining
the
molecular
basis
these
pathways,
particularly
crucial
roles
p53
signaling
miRNA
regulation,
we
highlight
how
their
dysregulation
contributes
to
resistance
tumor
progression.
The
synthesizes
recent
evidence
demonstrating
complex
interplay
between
ten
distinct
impact
on
microenvironment
immune
response.
We
evaluate
innovative
approaches
that
target
including
novel
small
molecules,
combination
strategies,
immunomodulatory
treatments
exploit
specific
enhance
efficacy.
Special
attention
is
given
personalized
medicine
strategies
consider
individual
characteristics
pathway
profiles.
integrating
current
challenges
with
future
research
directions,
this
framework
for
developing
more
effective
can
leverage
multiple
overcome
therapy
improve
outcomes
oral
cancer
patients.
Language: Английский
Panoptosis – new frontier in research in head neck cancer
Oral Oncology Reports,
Journal Year:
2024,
Volume and Issue:
10, P. 100310 - 100310
Published: April 5, 2024
Head
and
neck
squamous
cell
carcinoma
(HNSCC)
is
a
common
cancer
that
can
develop
resistance
to
therapeutic
approaches,
including
chemotherapy,
targeted
therapy,
immunotherapy.
PANoptosis,
non-apoptotic
death
mechanism,
has
been
identified
as
potential
solution.
PANoptosis
highly
coordinated
dynamically
balanced
programmed
inflammatory
pathway
combines
the
main
features
of
pyroptosis,
apoptosis,
necroptosis.
It
linked
development
multiple
systemic
diseases
in
human
body,
infectious
diseases,
cancer,
neurodegenerative
diseases.
The
innate
immune
system
provides
first
line
defense
against
cellular
perturbations,
elicited
response
microbial
infections
or
alterations
homeostasis.
Programmed
(PCD)
key
mechanism
for
studying
anticancer
drugs
significant
impact
on
management
cancer.
Recent
research
revealed
existence
distinct
PCD
modality
known
which
controlled
by
complex
PANoptosome
complexes
built
combining
elements
from
different
pathways.
No
single
route
sufficient
explain
all
physiologic
effects
seen
PANoptosis.
Numerous
studies
have
demonstrated
successfully
stop
cells
growing,
proliferating,
developing
drug
resistance,
changing
focus
therapy.
Language: Английский